The concentration problem
Compounded vials are not standardised across pharmacies. A "0.25 mg" instruction means a different number of syringe units depending on how many milligrams per millilitre your vial contains. This is why an online schedule is not transferable.
The two numbers that matter
Your prescribed dose in milligrams, and your vial concentration in milligrams per millilitre. Your clinician gives you the first; your label carries the second. Everything else is arithmetic your dispensed instructions should already do for you.
If the instructions are unclear
Do not estimate. Do not average what other people report. Call the pharmacy or your clinician and get the volume confirmed before you inject.
Trial results belong to the specific FDA-approved product studied, at the doses studied.
What is known about the molecule
FDA prescribing information describes tirzepatide as acting on GIP and GLP-1 receptors. SURMOUNT-1 in the New England Journal of Medicine studied the FDA-approved brand at protocol doses – not microdose schedules and not compounded preparations.
How this works here
Complete an intake, a licensed clinician reviews your case, and if treatment is appropriate a licensed U.S. pharmacy dispenses it with instructions written for your preparation. PinwellRx does not prescribe or compound. See the 30-second film answers for this medication.
What a titration schedule is actually for
Titration means starting at a dose below the one intended to be effective and stepping up on a schedule. It exists for tolerability, not caution for its own sake. Receptor signalling that arrives gradually gives the gut time to adapt, which is why the label sets minimum intervals between increases rather than leaving the pace open. Skipping ahead does not accelerate anything except side effects. Holding at a dose is a legitimate clinical decision, and so is stepping back down. If you want the lower end of that range as a deliberate plan rather than a waypoint, that is what microdosing describes. Your clinician sets the schedule, reviews how you are tolerating it, and adjusts. Nothing about a titration plan guarantees a particular result, and no schedule substitutes for the follow-up conversation that decides whether to continue.
A compounded preparation is not a generic of, or equivalent to, any FDA-approved product.
How tirzepatide works on two receptors at once
Tirzepatide is a single molecule that activates two incretin receptors: GIP and GLP-1. Both are receptors your gut already uses. After a meal, the intestine releases incretin hormones that tell the pancreas to release insulin, slow how fast the stomach empties, and signal fullness to the hypothalamus. Tirzepatide binds those same receptors, so the signal is present at a steadier level than it would be from food alone. The GLP-1 arm is the one most people have heard of. The GIP arm is what distinguishes tirzepatide from semaglutide, which acts on GLP-1 only. According to the FDA prescribing information for tirzepatide products, dual agonism is the mechanism of record. What that difference means for any individual is a clinical question, not a settled one, and a licensed clinician decides whether the medication is appropriate for you at all.
What compounded means, and what it does not
A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as SURMOUNT-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.
Why side effects are mostly digestive, and mostly early
Because the receptors tirzepatide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for tirzepatide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.
Answer a few questions. A licensed clinician decides what, if anything, is appropriate.
Frequently asked questions
Why will you not publish a dose?
Because a dose without your history and your vial concentration is a guess, and a guess with an injectable medication is dangerous.
How do I convert milligrams to units?
You should not have to. Your dispensed instructions should state the volume for your preparation. If they do not, ask before injecting.
Is a microdose safer than a standard dose?
Not automatically. Side effects can occur at any dose, and lower does not mean risk-free.
Who decides when to change it?
Your prescribing clinician, at follow-up.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is an FDA-approved product; a compounded preparation is made by a licensed pharmacy for an individual patient and is not FDA-approved. FDA does not review compounded preparations for safety, effectiveness, or quality before marketing, and a compounded preparation is not a generic or an equivalent.
What is the starting dose of compounded tirzepatide?
Your prescribing clinician sets the starting dose and the titration schedule, and the dispensing pharmacy supplies instructions for your specific concentration. There is no single published starting dose for compounded preparations, and units and milligrams are not interchangeable.
Have a clinician set your dose
Rx only, after review. About 10 minutes, and a full refund if you are not prescribed.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- FDAFDA prescribing information, tirzepatide (DailyMed)
- Peer-reviewedJastreboff AM et al. Tirzepatide once weekly for obesity (SURMOUNT-1). N Engl J Med 2022;387:205-216
- FDAFDA. Compounding and the FDA: questions and answers
- FDA databaseDrugs@FDA: search approved labeling for tirzepatide
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on GLP-1 Microdosing
Same medication, different question.
